On Monday, Mersana Therapeutics Inc (NASDAQ: MRSN) opened higher 3.03% from the last session, before settling in for the closing price of $0.46. Price fluctuations for MRSN have ranged from $0.45 to $5.15 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 12314.39% over the past five years. Company’s average yearly earnings per share was noted -28.16% at the time writing. With a float of $85.81 million, this company’s outstanding shares have now reached $115.65 million.
Let’s look at the performance matrix of the company that is accounted for 102 employees. In terms of profitability, gross margin is 56.37%, operating margin of -144.52%, and the pretax margin is -169.82%.
Mersana Therapeutics Inc (MRSN) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Mersana Therapeutics Inc is 31.15%, while institutional ownership is 54.62%. The most recent insider transaction that took place on Jan 16 ’25, was worth 2,061. In this transaction VP, Chief Accounting Officer of this company sold 3,554 shares at a rate of $0.58, taking the stock ownership to the 57,519 shares. Before that another transaction happened on Jan 16 ’25, when Company’s Director sold 8,637 for $0.58, making the entire transaction worth $5,009. This insider now owns 168,041 shares in total.
Mersana Therapeutics Inc (MRSN) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.2 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -28.16% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -13.09% during the next five years compared to 2.74% growth over the previous five years of trading.
Mersana Therapeutics Inc (NASDAQ: MRSN) Trading Performance Indicators
Check out the current performance indicators for Mersana Therapeutics Inc (MRSN). In the past quarter, the stock posted a quick ratio of 2.19. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.47.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.57, a number that is poised to hit -0.19 in the next quarter and is forecasted to reach -0.65 in one year’s time.
Technical Analysis of Mersana Therapeutics Inc (MRSN)
Mersana Therapeutics Inc (NASDAQ: MRSN) saw its 5-day average volume 2.73 million, a negative change from its year-to-date volume of 6.36 million. As of the previous 9 days, the stock’s Stochastic %D was 17.33%. Additionally, its Average True Range was 0.06.
During the past 100 days, Mersana Therapeutics Inc’s (MRSN) raw stochastic average was set at 1.56%, which indicates a significant decrease from 29.07% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 98.32% in the past 14 days, which was lower than the 145.42% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.6567, while its 200-day Moving Average is $1.6306. Nevertheless, the first resistance level for the watch stands at $0.4974 in the near term. At $0.5159, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.5437. If the price goes on to break the first support level at $0.4511, it is likely to go to the next support level at $0.4233. Assuming the price breaks the second support level, the third support level stands at $0.4048.
Mersana Therapeutics Inc (NASDAQ: MRSN) Key Stats
There are currently 124,631K shares outstanding in the company with a market cap of 59.70 million. Presently, the company’s annual sales total 40,500 K according to its annual income of -69,190 K. Last quarter, the company’s sales amounted to 16,360 K and its income totaled -14,120 K.
